Critical Reviews in Food Science and Nutrition
Research Applications This selective activity makes AOD9604 an attractive candidate for obesity treatment and body composition optimization research, as it theoretically provides the metabolic benefits of growth hormone for fat reduction without the growth-promoting effects that could stimulate cancer cell proliferation, cause acromegaly-like symptoms, or induce insulin resistance
In brief, it appears that ipamorelin can cause weight and muscle gain, while AOD-9604 may be a weight loss agent
Never blast liquid directly onto the peptide cake
Cagrilintide handles appetite suppression through the amylin pathway, while Semaglutide works through GLP-1 receptors
After 812 weeks on a medically guided protocol: Photos are not mandatory , but tracking body metrics like weight, circumference, or DEXA scans can help validate results